DOI QR코드

DOI QR Code

Running of high patient volume radiation oncology department during COVID-19 crisis in India: our institutional strategy

  • Gupta, Manoj (Department of Radiation Oncology, All India Institute of Medical Science) ;
  • Ahuja, Rachit (Department of Radiation Oncology, All India Institute of Medical Science) ;
  • Gupta, Sweety (Department of Radiation Oncology, All India Institute of Medical Science) ;
  • Joseph, Deepa (Department of Radiation Oncology, All India Institute of Medical Science) ;
  • Pasricha, Rajesh (Department of Radiation Oncology, All India Institute of Medical Science) ;
  • Verma, Swati (Department of Radiation Oncology, All India Institute of Medical Science) ;
  • Pandey, Laxman (Department of Radiation Oncology, All India Institute of Medical Science)
  • 투고 : 2020.04.04
  • 심사 : 2020.05.15
  • 발행 : 2020.06.30

초록

Purpose: Due to COVID 19 pandemic, the treatment of cancer patients has become a dilemma for every oncologist. Cancer patients are at an increased risk of immunosuppression and have a higher risk to acquire any infection. There are individual experiences from some centers regarding the management of cancer patients during such a crisis. So we have developed our institutional strategy to balance between COVID and cancer management. Materials and Methods: Radiation Oncology departmental meeting was held to prepare a consensus document on Radiotherapy schedules and department functioning during this pandemic. Results: Strategies were taken in form of following areas were steps need to be taken to decrease risk of infection, categorise treatment on the basis of priority, radiotherapy schedules modification, academic meetings and management of COVID positive patient/personnel in Radiation Oncology department. Conclusion: We hope to strike the balance in overcoming both the battles and emerge as winners. Stringent long term follow up will be done for assessing the response or any unforeseen treatment related sequelae.

키워드

참고문헌

  1. World Health Organization. Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) [Internet]. Geneva, Switzerland: World Health Organization; c2020 [cited 2020 May 15]. Available from: https://www.who.int/news-room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).
  2. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395:470-3. https://doi.org/10.1016/s0140-6736(20)30185-9
  3. Perlman S. Another decade, another Coronavirus. N Engl J Med 2020;382:760-2. https://doi.org/10.1056/NEJMe2001126
  4. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019;17:181-92. https://doi.org/10.1038/s41579-018-0118-9
  5. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016;14:523-34. https://doi.org/10.1038/nrmicro.2016.81
  6. Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis 2020;92:214-7. https://doi.org/10.1016/j.ijid.2020.01.050
  7. World Health Organization. Key considerations for repatriation and quarantine of travellers in relation to the outbreak of novel coronavirus 2019-nCoV [Internet]. Geneva, Switzerland: World Health Organization; c2020 [cited 2020 May 15]. Available from: https://www.who.int/news-room/articles-detail/key-considerations-for-repatriation-and-quarantine-of-travellers-in-relation-to-the-outbreak-of-novel-coronavirus-2019-ncov.
  8. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet]. Geneva, Switzerland: World Health Organization; c2020 [cited 2020 May 15]. Available from: https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19).
  9. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19) situation summary [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; c2020 [cited May 15]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/summary.html.
  10. World Health Organization. Novel Coronavirus - China [Internet]. Geneva, Switzerland: World Health Organization; c2020 [cited 2020 May 15]. Available from: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/.
  11. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019;144:1941-53. https://doi.org/10.1002/ijc.31937
  12. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335-7. https://doi.org/10.1016/s1470-2045(20)30096-6

피인용 문헌

  1. Prioritizing Delivery of Cancer Treatment During a COVID-19 Lockdown: The Experience of a Clinical Oncology Service in India vol.7, 2021, https://doi.org/10.1200/go.20.00433